Oklo Inc (OKLO) Stock Forecast & Price Target

Oklo is viewed favorably because it combines a vertically integrated build-own-operate model with commercial, binding demand from hyperscale customers, giving it a path to capture economics across power, fuel, recycling, and isotopes rather than acting as a narrow equipment vendor. Its first-of-a-kind 75 MW units are estimated at 6.5% unlevered IRRs versus 13% for nth-of-a-kind units, with potential ~60% EBITDA margins at scale, while the disclosed pipeline of about 18.1 GW and the Meta prepayment for up to 1.2 GW at Pike County provide meaningful validation and upfront capital for fuel procurement and site development. The outlook is further supported by regulatory and execution progress, including DOE approval of Aurora-INL’s PDSA, site work nearing completion ahead of a planned 2028 startup, first criticality at the Groves isotope reactor on August 5, 2026, and strategic acquisitions and fuel-supply agreements that strengthen Oklo’s ability to shorten the design-to-manufacture loop and de-risk deployment.

Oklo is viewed negatively because its investment case depends on a long chain of highly uncertain execution milestones, while management itself signals that key fuel-enrichment solutions such as Hexium’s AVLIS technology are still low-readiness and unlikely to be a near-term supply answer, leaving a critical HALEU constraint unresolved. The company is simultaneously building power plants, fuel fabrication, fuel recycling, and radioisotope businesses, but the excerpt shows limited disclosure around isotope economics, a need for capex ramping to $15M per year in 2026, only $10M of isotope revenue assumed in 2027 rising to $45M by 2030 and $278M by 2040, and an additional $650M of equity assumed in 2030 for construction working capital, all of which underscore a capital-intensive model with uncertain returns. Even with a modeled 35% ITC on capex through 2040 and monetization at 92% of face value, the updated forecast already reflects higher 2H26 capex, higher opex, and lower operating cash flow, while the reliance on pending DOE plutonium allocation decisions and broader diversified fuel strategy highlights material regulatory and supply risks that could delay commercial deployment and dilute shareholder value.